A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies.

Trial Profile

A Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Amrubicin (Primary) ; Cyclophosphamide
  • Indications Small cell lung cancer; Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2017 Results published in the American Journal of Clinical Oncology.
    • 16 Feb 2011 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
    • 16 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top